cgp-37849 cgp-37849 cgp-37849 is a competitive antagonist at the nmda receptor. it is a potent, orally active anticonvulsant in animal models, and was researched for the treatment of epilepsy. it also has neuroprotective activity and shows antidepressant and anxiolytic effects. cgp-37849clinical dataother namescgp-37849, cgp-40116identifiers iupac name (e,2r)-2-amino-4-methyl-5-phosphonopent-3-enoic acid cas number137424-81-8 ypubchem cid6604869chemspider5037128 nunii76ind1bs43chemblchembl29811 nchemical and physical dataformulac6h12no5pmolar mass209.138 g·mol−13d model (jsmol)interactive image smiles c/c(=c\(c(=o)o)n)/cp(=o)(o)o inchi inchi=1s/c6h12no5p/c1-4(3-13(10,11)12)2-5(7)6(8)9/h2,5h,3,7h2,1h3,(h,8,9)(h2,10,11,12)/b4-2+/t5-/m1/s1 nkey:bdyhnczigyiogj-xwcpemdwsa-n n ny (what is this?) (verify)